Literature DB >> 1370662

Enhanced mucosal cytokine production in inflammatory bowel disease.

W E Pullman1, S Elsbury, M Kobayashi, A J Hapel, W F Doe.   

Abstract

Proliferation, maturation, chemotaxis, and activation of neutrophils and monocytes are mediated largely by cytokines, including colony-stimulating factors and lymphokines. Cytokines produced in the intestinal mucosa contribute to the increased migration of neutrophils and monocytes into the lesion of inflammatory bowel disease and to the activation of these inflammatory cells. Lamina propria mononuclear cells isolated from colon tissue from 14 patients with inflammatory bowel disease (IBD) and from histologically normal controls were studied. Cells from IBD-affected tissue produced significantly more colony-stimulating factor activity (1402 +/- 252 U) per 2 x 10(6) cells than those from normal mucosa (362 +/- 85 U), mainly because of the increased production of granulocyte colony-stimulating factor and interleukin 1. This was accompanied by increases in the amount of specific messenger RNA for these two cytokines in lamina propria mononuclear cells from mucosa of patients with Crohn's disease (CD) compared with normal controls. By contrast, there was a substantial reduction in interleukin 3 production in CD and in ulcerative colitis lamina propria mononuclear cells, and this was reflected in significantly reduced expression of interleukin 3 messenger RNA in CD cells. Of the agents used in the therapy of IBD, hydrocortisone and 5-aminosalicylic acid, but not cyclosporin A, markedly suppressed in vitro production of cytokines by lamina propria mononuclear cells, suggesting that their therapeutic efficacy in vivo may be due in part to down-regulation of cytokine production in the inflamed mucosa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370662     DOI: 10.1016/0016-5085(92)90100-d

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

1.  Gastrointestinal lymphatics in health and disease.

Authors:  J S Alexander; Vijay C Ganta; P A Jordan; Marlys H Witte
Journal:  Pathophysiology       Date:  2010-09

Review 2.  The multifaceted effects of granulocyte colony-stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis.

Authors:  Andrew Martins; Jiahuai Han; Sung O Kim
Journal:  IUBMB Life       Date:  2010-08       Impact factor: 3.885

3.  Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity.

Authors:  C Schmidt; T Giese; B Ludwig; M Menges; M Schilling; S C Meuer; S Zeuzem; A Stallmach
Journal:  Int J Colorectal Dis       Date:  2005-08-23       Impact factor: 2.571

4.  Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Authors:  R Raqib; A A Lindberg; B Wretlind; P K Bardhan; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

Review 5.  Perspectives on osteoporosis in pediatric inflammatory bowel disease.

Authors:  Manisha Harpavat; David J Keljo
Journal:  Curr Gastroenterol Rep       Date:  2003-06

6.  Cytokines increase proliferation of human intestinal smooth muscle cells: possible role in inflammation-induced stricture formation.

Authors:  M W Owens; M B Grisham
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

7.  Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea.

Authors:  S Nicholls; S Stephens; C P Braegger; J A Walker-Smith; T T MacDonald
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

8.  Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.

Authors:  L Mazzucchelli; C Hauser; K Zgraggen; H Wagner; M Hess; J A Laissue; C Mueller
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

9.  Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease.

Authors:  J S Hyams; J E Fitzgerald; N Wyzga; W R Treem; C J Justinich; D L Kreutzer
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

10.  Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.

Authors:  G Bisping; N Lügering; S Lütke-Brintrup; H G Pauels; G Schürmann; W Domschke; T Kucharzik
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.